High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: Results of a randomised study

R. Fenk, P. Schneider, M. Kropff, A. N. Huenerlituerkoglu, U. Steidl, C. Aul, B. Hildebrandt, R. Haas, A. Heyll, G. Kobbe

Research output: Contribution to journal › Article › peer-review